
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Jefferies raised aTyr Pharma, Inc. (NASDAQ:ATYR) price target from $9 to $17. Jefferies analyst Roger Song maintained a Buy rating. aTyr Pharma shares closed at $4.95 on Thursday. See how other analysts view this stock.